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ABSTRACT 
Morphine typically produces analgesia in a variety of species 
by acting as an agonist at mu and perhaps delta opioid receptors. 
Recent research, however, has identified a biological model in 
which morphine produces a naloxone-reversible, paradoxical 
hyperalgesic response to a noxious thermal stimulus in young 
domestic fowl. The development of opiate receptor antagonists with 
selective activity at heterogeneous populations of opioid sites m^ 
be a useful tool to differentiate the action of an opiate at a 
particular receptor. In this stu<ty, the hyperalgesic actions of 
morphine (1.25 to 5.0 mg/kg im) on a standard hot-plate test were 
examined following administration (10 ug/5 ul icv) of the mu 
antagonist beta-funaltrexamine, the delta antagonist naltrindole, 
or the kappa antagonist nor-binaltorphamine in 15-day old White 
Leghorn cockerels. Morphine produced a dose-dependent decrease in 
mean jump latencies (i.e., hyperalgesia). Ma receptor antagonism 
attenuated morphine-induced hyperalgesia. Kappa receptor 
antagonism attenuated morphine-induced hyperalgesia only at the 
highest morphine dose (i.e., 5.0 mg/kg) and delta receptor 
antagonism failed to attenuate morphine-induced hyperalgesia. 
These results support the notion that at^ical morphine-induced 
hyperalgesia, like morphine-induced analgesia, is mediated 
primarily hy mu receptor activation. 
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iNnmjcncN 
Since the discovery of the endogenous opioids (Hughes, 1975; 
Hughes, Ehiith, Kosterlitz, Fothergill, ftorgan, & Marris, 1975; Li & 
Chung, 1976) and their receptors (Pert & Snyder, 1973; Simon, 
Hiller, & Edelmand, 1973; Terenius, 1973), considerable research 
has examined their participation in the regulation of various 
behaviors. Research with opiate agonists and antagonists has 
demonstrated that opioid ^ stems are involved in a variety of 
phencanena. These phenomena include learning and memory (Belluzzi & 
Stein, 1982; Gallagher, Kapp, McNall, & Pascoe, 1981; Squire & 
Davis, 1981), ingestive behaviors (Brown & Holtzman, 1981; 
McCormack & Denbow, 1987), sexual behaviors (Allen, Renner, & 
Luine, 1985; Pelligrini-Quarantotti, Corda, Paglietti Biggio, & 
Cessa, 1978; Pfaus & Gorzalka, 1987), social behaviors (Herman & 
Panksepp, 1978; Panksepp, Herman, Vilberg, Bishop, DeEskinazi, 
1980; Panksepp, Siviy, & Normansell, 1985), thermoregulation 
(Adler, Keinath, & Geller, 1980; Clark, 1979; Prohm & Wallnau, 
1983), respiration (Borison, 1977; Butland, Woodcock, Gross, & 
Geddes, 1981; Eckenhoff & Oech, 1960), and pain (Pasternak, 1981; 
Terenius, 1982; Yeung & Ru(ty, 1980). 
Opioid ^sterns, like other neurotransmitter systems (e.g., 
cholinergic & monoaminergic), can be divided into several 
sub^stems on the basis of receptor type. Initial evidence for 
different types of opioid receptors was provided by the 
3 
demonstration that various opiate agonists exhibit differential 
binding characteristics to opioid receptors (Martin, 1967). 
Further research demonstrated that different pharmacological 
profiles exist for various opiate alkaloids in the prevention of 
withdrawal syirptoms in morphine-dependent dogs (Martin, Eades, 
Thompson, HuppLer, & Gilbert, 1976). These observations suggested 
the existence of distinct opioid receptor subtypes. Additional 
support for and further definition of opioid receptor subtypes was 
subsequently provided by radioligand binding studies (for review 
see Itzhak, 1988). These studies have identified heterogeneous 
populations of opioid receptors based on the distinctive 
pharmacologic binding profiles for various opioid ligands and 
opiate antagonists. Current evidence suggests the existence of 
populations of mu, kagpa, delta, and possibly sigma opioid 
receptors sites. 
Current evidence supports the notion that opioid receptor 
subtypes are differentially involved in the expression of various 
behaviors. For example, most opioid receptor subtypes (i.e., mu, 
kappa, & delta) are involved in nociception. Food transit and 
respiratory regulation, however, are primarily mediated by mu 
receptors. In contrast, food intake and sedation principally 
involves kappa receptor activity, whereas emotional behaviors 
involve mostly delta receptor activity (see reviews by Martin, 
1984; Tam, 1989). 
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Cpiate agonists (e.g., morphine) typically produce analgesia 
in a variety of species (Bardo & Hughes, 1978, DeFeudis, DeFeudis, 
& Somoza, 1976; Giordano & Barr, 1987; Martin, Eades, Fraser, & 
Wikler, 1964; Yaksh & Ru(fy, 1977). These analgesic effects result 
frcan the activation of an opioid-mediated antinociceptive mechanism 
located in the central nervous system (CNS). This pain-inhibition 
system originates in the opioid-rich periaqueductal gray (PAG), 
projects to the nucleus raphe magnus, and descends via the 
dorsolateral funiculus to interneurons located in the dorsal horn 
of the spinal cord (Basbaum & Fields, 1978, 1984; Watkins & Mayer, 
1982). ^stemically and centrally administered opiates exert their 
analgesic effects by binding to mu receptors located in the PAG. 
The ultimate locus of these antinociceptive effects, however, 
occurs in the spinal cord dorsal horn via presynaptic inhibition of 
substance P-secreting sensory neurons (Oliveras, Besson, Guilbaud, 
& Liebeskind, 1974; Share & Rackham, 1981). In addition to this 
mu-mediated pain inhibition ^ stem, opiate-induced analgesia can be 
elicited by kappa and, to a lesser extent, delta receptor 
activation within the nociceptive neuraxis (Tarn, 1989). 
Although most animals display an analgesic response to 
morphine, recent research has identified a biological model in 
which morphine produced a strain-dependent hyperalgesic response 
(Hughes, in press-a & b; Sufka & Hughes, 1990b). In these studies, 
various doses of morphine (2.5 to 30.0 mg/kg) decreased response 
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latencies (i.e., hyperalgesia) to a noxious thermal stimulus in 
young donestic fowl. This atypical morphine effect was 
naloxone-reversible (Hughes, in press-a) and exhibited dose and 
temporal parameters (Sufka & Hughes, 1990b) characteristic of 
opiate analgesic effects. These observations suggest that 
morphine-induced hyperalgesia acts at opioid receptors. 
Significant advances in opioid-mediated behavioral 
pharmacology resulted fron the development of selective opiate 
receptor agonists and antagonists. These canpounds have enabled 
researchers to examine receptor subtype involvement in the 
expression of various behaviors (e.g., nociception, respiration, 
thermoregulation, etc. ). Although seme canpounds exhibit greater 
selectivity than others, three relatively selective opioid receptor 
antagonists (beta-funaltrexamine: Takemori, Larson, & Portoghese, 
1981; Ward, Portoghese, & Takemori, 1982, nor-binaltorphamine: 
Portoghese, Lipkowski, & Takemori, 1987; Portoghese, Nagase, 
Lipkowski, Larson, & Takemori, 1988a, & naltrindole: Portoghese, 
Sultana, Nagase, & Takemori, 1988b) are available to evaluate the 
involvement of opioid receptor subtypes in the expression of 
morphine-induced hyperalgesia. Through selective blockade of 
opioid receptors with selective opiate receptor antagonists, the 
contribution of mu, kappa, and delta receptor activity in 
morphine's hyperalgesic effects can be examined. The present 
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researchf therefore, sought to determine the contribution of 
various opioid receptor subtypes in the expression of this 
paradoxical opiate effect in domestic fowl^ 
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EXPERIMENT ŒE 
Morphine, at lew doses, is a relatively selective inu receptor 
agonist (Martin, 1984) and in mammals exerts its analgesic effects 
through the activation of QîS receptors located in the PAG (Wood, 
Rackham, & Richard, 1981; Yaksh & Rucfy, 1978). Hyperalgesic 
effects have been reported at a relatively lew morphine dose (i.e., 
2.5 mg/kg; Sufka & Hughes, 1990b). The effectiveness of this dose 
suggests that the paradoxical hyper algesic effects of morfMne is 
from mu receptor activation. 
The use of a selective mu antagonist can directly test the 
contribution of mu receptors in the expression of morgdiine-induced 
hyperalgesia in domestic fewl. Irreversible mu receptor blockade 
can be accranplished by administration of beta-funaltrexamine 
(beta-ENA). Beta-ETîA is an opioid receptor alkylating agent that 
demonstrates reversible kappa agonist effects and irreversible mu 
antagonist effects (Takemori et al., 1981; Ward et al., 1982). The 
kappa agonist activity of beta-ETJA is of short duration (i.e., 
several hours). Peak mu antagonism, however, occurs 12 to 24 hrs 
after intracerebroventricular (icv) administration (Ward et al., 
1982). If morphine-induced hyperalgesia reflects the activation of 
CNS mu receptors, then beta-FNA administration should attenuate 
morphine effects. Experiment 1 was designed to examine morpdiine 
effects on nociception following selective antagonism of mu 
receptors. 
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Opiates are also known to influence qrstems related to 
thermoregulation (Adler et al., 1980; Clark, 1979; Frohm & Wallnau, 
1983) and respiration (Butland et al., 1981; Borison, 1977; 
Eckenhoff & Oech, 1960). In mammals, opiate agonists lower core 
bo<fy temperature (Tam, 1989) and depress respiration (Green, 1959; 
Ling, %)iegel, Lockhart, & Pasternak, 1985; McGilliard & Takemori, 
1978; McQueen, 1983) through mu receptor activation. 
Morphine-induced hyperalgesia may result through non-mu mechanisms 
and thereby result in non-significant differences between the 
saline and beta-EîîA treatments. Therefore, bocfy temperature and 
respiration measures were included in the present stucty to rule out 
a variety of alternative interpretations (e.g., biologically 
inactive antagonist) of the nociceptive data. 
Method 
Subjects. Chicks (Welp-Line 542 cockerels commercial 
stock) were obtained from Welp Incorporated (Bancroft, Iowa) 1-day 
post-hatch and were housed in pairs in chambers that provided 
physical separation but not auditory or visual isolation. This 
housing procedure (described below), compared to housing 
chicks in brooders, enables researchers to locate and capture 
animals with minimal disruption to the brood and eliminates many 
procedural problems (e.g., social isolation and/or social 
aggression confounds during injection-to-test intervals) associated 
with communal housing. Animals were housed under continuous 
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illumination with free access to food (Wayne pullet starter) and 
water. Room temperature was maintained at 32 ± 1 °C for the first 
week and at 29 + 1 °C thereafter. 
Housing apparatus. Four separate 186 x 62 x 37 an 
enclosures were constructed. Each enclosure was divided into 
twelve 31 X 31 X 37 cm individual housing units. The outside 
perimeter walls were fabricated from 16-gauge aluminum sheeting and 
were painted gray. The floor of the housing apparatus was 
constucted fran 2.5 cm expansion metal. The internal walls of the 
housing apparatus and the lids covering each individual unit were 
constructed of 2 x 2 hardware cloth. The lids were covered with 
white broadcloth. Illumination was provided by a 12-W fluorescent 
light bulb that was centered at the top and extended from end to 
end of the housing facility. Pood was available from 1/4 round 
stainless steel feeders. Water was available from J-shaped 
waterers mounted outside the chamber with the drinking spout 
protruding through a 3 cm diameter opening into each housing unit. 
Test apparatus. Jump latency in response to a thermal 
stimulus was used as the index of nociception. The apparatus was a 
modified version (Hughes & Sufka, in press) of the typical 
hot-plate apparatus that is often used to assess thermal 
nociception in rats (D'Amour & Smith, 1941). The grid-like floor 
of the apparatus consisted of a 63 x 20 x 0.3 cm copper plate with 
six 1.5 an diameter copper tubes filled with lead shot. The tubes 
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were spaced 0.9 am center to center and were attached to the middle 
12.5 cm of the copper plate. The copper plate was supported by a 
63 X 19 X 7 cm wood base with a 23 x 7 cm opening in the front 
which enabled placement of a single element hot plate (750 W 
Hamilton Beach, tbdel 812) under the center portion of the copper 
plate. The thermostatic control of the hot plate was disconnected 
and ten^jerature was regulated by a variable transformer (Stayco 
Energy Products Co., 3PN1010). Teirperature was monitored by a 
digital thermometer (Fluke, Model 52) from a thermister imbedded in 
the upper surface of one of the center middle copper tubes. A 17 x 
16 X 31 cm Plexiglas chamber with a hinged lid was fitted over the 
tubes. The outside chamber walls were covered with onion skin 
paper. A 3.5 x 16 cm opening at the base of the front wall 
remained uncovered to permit observation. All other exposed copper 
areas outside of the chamber were covered with 2.5 cm Styrofoam 
which was fastened to the base with duct tape. Response latencies 
were recorded to the nearest 0.1 second via an electronic timer 
(Hunter, Model 120A). 
Procedure 
Injections. The groups in this stu^ formed a 2 (saline or 
beta-PNA 10 ug in 5 ul icv) x 4 (1.25, 2.5, or 5.0 mg/ml/kg 
morphine or saline 1 ml/kg im; n = 10 per cell) factorial design. 
All drugs were dissolved in pyrogen-free saline. Chick pairs from 
each individual housing unit received either icv saline or beta-FNA 
11 
approximately 20 hours before hot-plate tests. A 10 ul Hamilton 
microsyringe was used to manually deliver icv injections directly 
through the skull immediately anterior to the cerebellum into the 
vicinity of the 4th ventricle (location identified by ^ e injection 
in a separate group of chicks). Drugs (icv) were delivered at a 
rate of 1 ul per 5 sec and followed by a 15 sec interval before the 
microsyringe was removed. Animals were returned to their home 
cage immediately after injections. Chick pairs from each 
individual housing unit were randomly assigned to one of the three 
morphine dose treatments or to the saline control treatment. 
Thirty minutes before hot plate tests, 14-day old chicks were 
removed from their cage, weighed (to the nearest 0.1 g), and given 
an im injection of morphine or saline and returned to their hone 
cage. 
Thermal nociceptive tests. Thirty minutes after morphine 
injections, a chick was placed into a 2 quart opaque plastic 
container which was covered with a vented lid. The animal was 
transported to an adjacent room where tests were administered. The 
chick was ronoved from the container and first placed on a 
hot-plate grid maintained at room temperature (25 °C). An 
electronic timer was started by a manual switch as the chick's feet 
touched the apparatus floor and was manually terminated following a 
jump response or after attainment of a 70 sec no-jump criterion. A 
jump response was defined as an upward thrust of the animal's body 
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with both feet off the grid floor. The chick was removed frran the 
apparatus following a juirp response or after attainment of the 70 
sec no-jump criterion and was immediately tested on a heated grid 
(60 °C). 
Body temperature and respiration measures. Immediately 
following hot-plate tests, bo^ temperature and respirations were 
measured. Bo<^ temperature measures were taken (Markson, Itodel 91) 
60 sec after insertion of a 0.5 cm diameter thermister (YSI, Madel 
702) 2 cm into the cloaca. During this interval, respirations 
(i.e., rtythmic chest movements) were counted by a trained 
observer. All experimenters were blind to the treatment 
conditions. Chicks were returned to their home cage following 
tests. 
Statistics. Data were analyzed using a 2-w^ ANCWA. 
Factors were Drug (saline or beta-ENA) and Dose (0.0, 1.25, 2.5, & 
5.0 mg/kg morphine). Simple effects analyses were used to identify 
sources of significant interactions. Multiple t-statisties 
(one-tailed) were used to test a priori orthogonal contrasts. 
These contrast identified which morjAiine dose produced significant 
hyperalgesia and then determined if the opiate antagonist treatment 
attenuated morphine effects. 
Results 
Dye spread. Verification of ^ e spread in a separate group 
of chicks was conducted with reference to the coordinates of van 
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Tienhoven and Juhasz (1962) 30 min post-icv blue (fye injection. 
Chicks (n = 8) were sacrificed by r^id decapitation and whole 
brains were iirmediately removed fran the calvarium. A midsagittal 
incision through the longitudinal fissure was performed. For each 
chick brain, <^e diffusion was observed throughout the entire 
ventricular ^stem. Moreover, blue stain was observed to penetrate 
approximately 1.5 mm into the neural tissue surrounding the 
ventricular ^stem. 
The icv method of administering drugs to the experimental 
animals produced no observable chronic changes in the animals 
behavior. Some chicks (less than 10%) did display acute motor 
(tysfunction (lasting approximately 15 sec) and/or a atiall amount of 
bleeding fran the injection site. The gross behavior state of the 
chicks at the time of the thermal nociceptive tests, however, 
was indistinguishable from non-injected chicks. 
Jump latency. The effects of beta-ENA on morphine-induced 
hyperalgesia are presented in Figure 1. Marphine produced a 
dose-dependent decrease in mean jump latencies in chicks that 
received icv/saline administration. This morjAiine-induced 
hyperalgesic effect was attenuated by icv/beta-ENA administration. 
A 2-way ANWA performed on these data revealed significant 
treatment effects for Drug [£(1,72) = 11.99, B<.01] and Dose 
[£(3,72) = 10.16, E<.01]. The Drug x Dose interaction term was not 
significant [£(3,72) = 1.85]. Subsequent analysis of the jump 
Figure 1. ffean jump latency as a function of morgdiine dose for 
chicks treated with the selective mu antagonist beta-
funaltrexamine (10 pg/5 pi icv) or saline (vertical lines 
= SEM) 
o saline 
• beta-FN A 
I I I I 
0.0 1.25 2.5 5.0 
MORPHINE DOSE (mg/kg) 
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latency data for icv/saline groups demonstated that the mean juirp 
latencies for the 2.5 and 5.0 mg/kg morphine dose groups were 
significantly shorter than the mean jump latency of the saline 
control group [t®(72) = 4.02 and 5.32, respectively, e®<.01]. 
Further analysis demonstrated that the mean juirp latencies of the 
icv/beta-ENA groups at the 2.5 and 5.0 mg/kg morjAiine doses were 
significantly longer than the mean jump latencies for comparable 
icv/saline groups [t®{72) = 2.11 and 3.22, e®<.05 and .01, 
respectively]. Jump latencies f ran ambient temperature tests were 
not analyzed since animals reached the 70 sec no-jump criterion on 
98% (78/80) of the tests at ambient grid temperature. 
Respiration. As is evident in Figure 2, morphine produced 
a dose-dependent decrease in mean respirations in the icv/saline 
groups and this decrease was attenuated by icv/beta-ENA 
administration. A 2-w^ ANOVA performed on these data revealed 
significant treatment effects for Drug [F(l,72) = 7.13, p<.01], 
Dose [F(3,72) = 19.76, p<.01], and a significant Drug x Dose 
interaction [£(3,72) = 5.30, p<.01]. Analysis of simple main 
effects yielded significant Dose effects at each drug level 
[saline, F(3,72) = 22.27, P<.01; beta-ENA, F(3,72) = 2.78, E<.05] 
and a significant Drug effect at only the 5.0 mg/kg Dose treatment 
[£(3,72) = 4.01, E<.01]. 
Body temperature. As shown in Figure 3, morphine produced 
a dose-dependent decrease in mean bo<^ temperature that was most 
Figure 2. Mean re^i rations (1 minute) as a function of 
morgdiine dose for chicks treated with the selctive mu 
antagonist beta-funaltrexamine (10 pg/5 pi icv) or saline 
(vertical lines = SEM) 
o saline 
e beta-FNA 
I 
T— 
1.25 
"T" 
2.5 0.0 
MORPHINE DOSE (mg/kg) 
5.0 
Figure 3. Mean bcx^ temperature as a function of morjAine dose for 
chicks treated with the selective mu antagonist beta-
funaltrexamine (10 pg/5 pi icv) or saline (vertical lines 
= SEN) 
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pronounced at the 1.25 mg/kg dose for icv/saline groups. TOie 
pattern of morphine effects displayed by chicks that received 
icv/beta-ENA administration was similar to the pattern of effects 
of the icv/saline treated chicks. A 2-way ANŒ/A revealed a 
significant treatment effect for Dose [F(3,72) = 3.07, p<.05]. The 
Drug and Drug x Dose interaction terms were not significant. 
Further analysis of the icv/saline groups demonstrated that the 
mean body temperatures for the 1.25 [t(72) = 2.65, pC.Ol] and 5.0 
mg/kg [t(72) = 2.05, 2<.05] morfMne dose groups were significantly 
lower than the mean bo(ty temperature of the saline control group. 
Discussion 
E}çeriment 1 was designed to determine the contribution 
of mu receptor activation in the expression of morphine-induced 
hyperalgesia. Morphine dose-response effects on thermal 
nociception were evaluated following icv administration of the 
selective irreversible mu antagonist beta-ENA or saline in young 
domestic fowl. Consistent with earlier reports (Sufka & Hughes, 
1990b), morphine produced a dose-dependent decrease in mean jump 
latency (i.e., hyperalgesia) in icv/saline control animals. Ma 
receptor antagonism with beta-ENA attenuated this hyperalgesic 
response. In most species, morphine produces analgesia through mu 
receptor activation (Yaksh & Ructy, 1978). The present research 
implicates similar mu receptor involvement in the expression of 
morphine-induced hyperalgesia in this animal model. 
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Morphine is known to decrease respiration (Green, 1959; Ling 
et al., 1985; MoGilliard & Takemori, 1978; McQueen, 1983) and body 
temperature (Tarn, 1989) through mu receptor activation. The 
possibility that hyperalgesia may involve non-mu mechanisms 
prompted the use of these two additional dependent measures. Bo(^ 
temperature and respiration should be sensitive measures of opiate 
agonist and possibly mu antagonist manipulations. In the present 
research, morphine produced a dose-dependent decrease in mean 
respirations. Mareover, this respiratory depression was attenuated 
by administration of the selective mu antagonist beta-FNA. These 
results with domestic fowl are consistent with earlier research 
that demonstrated mu receptor involvement in the regulation of 
respiration in other species (Green, 1959; Ling et al., 1985; 
MoGilliard & Takemori, 1978; McQueen, 1983). 
In the present research, morphine produced a dose-dependent 
decrease in mean bo^ tençerature. These results are consistent 
with earlier reports of morphine effects on thermoregulation in 
rats (Adler et al.,-1980; Clark, 1979) and in domestic fowl (Prohm 
& Wallnau, 1983). Beta-ENA, however, failed to reverse 
morphine-induced hypothermia. These results are inconsistent with 
earlier research that demonstrated decreased core temperatures 
through mu receptor activation in chronic spinal dogs (Martin, 
Eades, Thompson, Huppler, & Gilbert, 1976; Tarn, 1989). A number of 
factors may account for the failure of beta-FNA to attenuate 
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morphine-induced hypothermia. For example, social separation can 
induce hyperthermia in domestic fowl (Frohm & Wallnau, 1983; Sufka 
& Hughes, 1990b). The experimental protocol in the present 
research involved social separation. This manipulation may have 
influenced thermoregulatory systems in such a way as to conpete 
with beta-ENA fran attenuating morphine-induced hypothermia. 
Perhaps higher doses of beta-FNA would permit sufficient 
bioavailabilty of the antagonists to act on thermoregulatory 
systems and attenuate morphine-induced hypothermia. It is also 
possible that in domestic fcwl opiate agonists influence 
thermoregulation through non-mu mechanisms (Tam, 1989). 
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EXPERIfENT TWO 
Regional distribution of opioid receptor subtypes and their 
selectivity to bind various endogenous opioid peptides varies 
markedly in the QJS. Considerable overlap in regional distribution 
and ligand binding, however, exists between mu and delta receptors 
(Goodman, Adler, & Pasternak, 1988; Itzhak, 1988; Tarn, 1989). 
Although morphine is relatively selective to mu sites and the 
results of Experiment 1 demonstrated a significant mu component in 
this paradoxical opiate effect, hyperalgesia in domestic fowl may, 
in part, reflect the co-activation of morjAiine at mu and delta 
receptor sites. If morphine-induced hyperalgesia results fran 
concomitant activation of mu and delta sites, then administration 
of the selective delta antagonist naltrindole (Portoghese et al., 
1988b) should partially attenuate morjAiine effects. Unlike 
beta-FNA, naltrindole (NTI) directly antagonizes receptor sites. 
The temporal characteristics of NTI, therefore, are similar to most 
other direct-acting opiate antagonist (e.g., naloxone). The 
purpose of the present experiment was to determine the contribution 
of delta receptor activity in the expression of morphine-induced 
hyperalgesia, respiratory depression, and hypothermia by examining 
morphine dose-response effects following selective antagonism of 
delta receptors. 
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Method 
Subject characteristics, housing conditions, and test 
apparatus were as described in Experiment 1. 
Procedure 
The experimental procedures were as described in Experiment 1 
except that icv administration of NTI or saline (10 ug in 5 ul) 
occurred at the same time as im morphine injections (i.e., 30 min 
before hot-plate tests). Statistical analysis of the data was as 
described in Experiment 1. 
Results 
Jump latency. Bie effects of NTI on morphine-induced 
hyperalgesia are shown in Figure 4. ftorjAiine produced a 
dose-dependent decrease in mean jump latencies in both the 
icy/saline and icv/NTI groups. This hyperalgesic effect was 
partially attenuated in the icv/NTI groups at the 2.5 and 5.0 mg/kg 
morjMne dose groups. A 2-way MOJh, however, revealed significant 
treatment effects for Dose only [£(3,72) = 13.55, jo<.01]. 
Subsequent analysis of these data for icv/saline groups 
demonstrated that the mean jump latencies for the 1.25 [t(72) = 
2.34, e<.05], 2.5 [t(72) = 4.12,e<.01], and 5.0 mg/kg [t(72) = 
4.98, E<.01] morphine dose groups were significantly shorter than 
the mean jump latency of the saline control group. T-tests between 
the mean jump latencies of the icv/saline and icv/NTI groups at 
each morphine dose failed to reveal a significant attenuation of 
Figure 4. Mean junp latency as a function of morjAiine dose for 
chicks treated the selective delta antagonist 
naltrindole (10 pg/5 pi icv) or saline (vertical lines 
SEM) 
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morphine-induced hyperalgesia. Jump latencies fron ambient 
temperature tests were not analyzed since animals reached the 70 
sec no-jump criterion on all of the tests at ambient grid 
tençerature. 
Respiration. As is evident in Figure 5, morphine produced 
a dose-dependent decrease in mean respirations in both icv/saline 
and icv/NTI groups. A 2-way ANŒ/A of these data revealed a 
significant treatment effect for Dose [£(3,72) = 20.28, E<.01]. 
The Drug and Dose x Drug interaction terms were not significant. 
Subsequent analysis of the respiration data for the icv/saline 
groups revealed that the mean respirations of the 2.5 [t{72) = 
2.65, E<.01] and 5.0 mg/kg [t(72) = 4.61, e<.01] morphine dose 
groups were significantly lower than the mean respirations of the 
saline control group. 
Body temperature. %e results of NTI administration on 
morphine dose-response effects on bo<^ temperature are presented in 
Figure 6. Marphine produced a dose-dependent decrease in mean bo<^ 
temperature. The icv/NTI groups, however, displayed higher mean 
bo<fy temperatures than the icv/saline groups at each morphine dose. 
A 2-w^ ANCWA of these data revealed significant effects for Drug 
[£(1,72) = 6.46, E<.05] and Dose [£(3,72) = 3.45, E<.05]. The Drug 
X Dose interaction term was not significant. Subsequent analysis 
of the bo<ty temperature data for the icv/saline groups demonstrated 
that the mean bo^ temperature for the 1.25 mg/kg morphine dose 
Figure 5. ffean respirations (1 minute) as a function of mor^ne 
dose for chicks treated with the selctive delta 
antagonist naltrindole (10 pg/5 pi icv) or saline 
(vertical lines = SEN) 
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Figure 6 .  Msan bo(^ temperature as a function of morphine dose for 
chicks treated with the selective delta antagonist 
naltrindole (10 pg/5 pi icv) or saline (vertical lines = 
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group was significantly Icwer than the mean bo<ty temperature of 
the saline control group [t(72) = 2.13, E<.051. Analysis of the 
bo(ty temperature data for animals that received icv/NTI 
demonstrated that the 1.25 tt(72) = 2.17, e<,05] and 5.0 mg/kg 
[t(72) = 2.13, E<.05] morphine dose groups had significantly lower 
mean bo^ temperatures than the mean body temperature of the saline 
control group. 
Discussion 
The purpose of Experiment 2 was to determine the contribution 
of delta receptor activity in the expression of morphine-induced 
hyperalgesia, respiratory depression, and hypothermia in dranestic 
fowl. Morphine dose-response effects on thermal nociception were 
examined following icv administration of the selective delta 
antagonist NTI or saline. As in the previous experiment, morphine 
produced a dose-dependent decrease in mean jump latencies (i.e., 
hyperalgesia) in the icv/saline groups. Administration of NTI 
failed to reverse this morphine hyperalgesic effect at the dose of 
NTI selected (10 ug). That delta receptor blockade failed to 
attenuate morphine effects suggests hyperalgesia is produced 
through Qrstems not extensively dependent upon delta activation. 
Previous research demonstrated that delta receptors are only 
minimally involved in nociceptive processes (Tam, 1989). Moreover, 
the analgesic action of delta ligands typically results through 
ligand binding to mu receptor sites (Clark, Itzhak, Hruby, 
34 
Yamamura, & Pasternak, 1986; Itzhak & Pasternak, 1987). The 
results of the present research, therefore, are consistent with 
earlier observations that delta systems are only minimally involved 
in nociception. 
Selective delta antagonism in the present experiment failed to 
attenuate morphine effects on respiration. These results suggest 
that morphine effects on respiration in domestic fowl occur through 
systems not dependent upon delta receptor activation. As in 
Experiment 1, morphine produced a dose-dependent decrease in mean 
respirations. This finding is consistent with earlier research 
that demonstrated mu-mediation of morphine-induced respiratory 
depression (Green, 1959; Ling et al., 1985; McGilliard & Takemori, 
1978, PfcQueen, 1983). 
Consistent with earlier research in domestic fowl (Frohm & 
Wallnau, 1983) and the results fron Experiment 1, morphine produced 
a dose-dependent decrease in mean bo^ temperatures. Selective 
delta antagonism increased mean bo^ temperature and this increase 
was independent of the pattern of morphine-induced hypothermia. 
These results suggest that endogenous thermoregulatory mechanisms 
are dependent upon functional delta sites and that morphine effects 
on thermoregulation are independent upon functional delta sites. 
Earlier research demonstrated that stress, such as social 
separation, can produce hyperthermic states in domestic fowl (Frohm 
& Wallnau, 1983; Sufka & Hughes, 1990a). These observations of 
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stress-induced hyperthermia and the results from the present 
experiment suggest that delta opioid ^sterns may play an inportant 
role in this stress phenomenon. 
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EXPERIIENT THREE 
Although the results frran Experiment 1 support the notion 
that morphine-induced hyperalgesia is mediated by mu systems, 
several models implicate kappa system involvement in this 
paradoxical opiate effect. For exanple, ka^a receptor agonists 
administered to medullary loci can elicit hyperalgesia in acutely 
decerebrate dogs (Wu, ffartin, Kamerling, fie Wettstein, 1983). 
Hyperalgesia has also been observed following local activation of 
primary sensory neurons that bear kappa receptors (van der Kopy & 
Nagy, 1985). The contribution of kappa receptor activation in the 
expression of morphine-induced hyperalgesia, however, is unknown. 
Through the use of selective kappa opiate antagonists [e.g., 
nor-binaltorphimine (nor-BNI); Portoghese et al., 1987; Portoghese 
et al., 1988a] kafpa receptor involvement in the expression of 
morphine-induced hyperalgesia in domestic fowl effect can be 
evaluated. If morphine-induced hyperalgesia reflects the 
concomitant activation of kappa and mu receptors, then nor-BNI 
should partially attenuate morphine effects. The purpose of the 
present stu<^, therefore, was to determine the contribution of 
kappa receptor activity in the expression of morphine-induced 
hyperalgesia, respiratory depression, and hypothermia by examining 
morphine effects following selective kaj^ receptor blockade. 
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Method 
Subject characteristics, housing conditions and test apparatus 
were as described in Experiment 1. 
Procedure 
The experimental procedures were as described in Experiment 2 
except that the opiate antagonist administered was nor-BNI. 
Statistical analysis of the data was as described in Experiment 1. 
Results 
Jump latency. Uie effects of nor-BNI on morphine-induced 
hyperalgesia are shown in Figure 7. Morphine produced a 
dose-dependent decrease in mean junp latencies in the icv/saline 
groups. This hyperalgesia effect was attenuated by nor-BNI at the 
higher morphine doses (i.e., 2.5 & 5.0 mg/kg). A 2-way ANWA 
revealed a significant effect for Dose [P(3,72) = 15.40, p<.01], a 
marginally significant effect for Drug [F(l,72) = 3.54, p = .06], 
and a non-significant Drug x Dose interaction. Subsequent analyses 
of these data for the icv/saline groups demonstrated that the mean 
jurrp latencies for the 2.5 [t(72) = 4.19, and 5.0 mg/kg 
tt(72) = 5.20, E<.01] morphine dose groups were significantly 
shorter than the mean jump latency of the control group. Moreover, 
at the 5.0 mg/kg morphine dose, the mean jump latency of the 
icv/nor-BNI group was significantly longer than the mean jump 
latency of the icv/saline group [t(72) = 1.94, E<.05]. Junp 
latencies from ambient temperature tests were not analyzed since 
Figure 7. Mean jump latency as a function of morgtiine dose for 
chicks treated with the selective ka^a antagonist nor-
binaltorphamine (10 pg/5 pi icv) or saline (vertical 
lines = SEN) 
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animals reached the 70 sec no-jump criterion on all of the tests at 
ambient grid tenperature. 
Respiration. As is evident in Figure 8, morphine produced 
a dose-dependent decrease in mean respirations and administration 
of nor-ENI was ineffective in attenuating this respiratory 
depression. A 2-w^ ANWA of these data revealed a significant 
treatment effect for Dose [F(3,72) = 24.49, E<.01]. The Drug and 
Drug X Dose interaction terms were not significant. Subsequent 
analysis of the respiration data of the icv/saline groups 
demonstrated that the mean respirations of the 1.25 [t(72) = 3.02 
p<.01], 2.5 [t(72) = 3.97, E<.01], and 5.0 mg/kg [t(72) = 6.76, 
E<»01] morjAiine groups were significantly shorter than the mean 
respirations of the saline control group. 
Body temperature. The effects of nor-ENI on 
morphine-induced hypothermia are shown in figure 9. For the 
icv/saline groups, morphine produced only a slight decrease in mean 
body temperature. This apparent lack of morphine effect may be 
related to the unusually low mean bo<ty temperature for the control 
group compared to the controls fran the first two experiments. For 
icv/nor-ENI group, however, morphine produced a dose-dependent 
decrease in mean bo^ temperature. Additionally, the icv/nor-BNI 
groups had higher mean bo(ty temperatures than did the icv/saline 
groups. A 2-way ANOVA revealed a significant effect for Drug 
[£(1,72) = 6.92, E<.01]. The Dose and Drug x Dose interaction 
Figure 8. Mean respirations (1 minute) as a function of morphine 
dose for chicks treated with the selctive kappa 
antagonist nor-binaltorphamine (10 pg/5 pi icv) or saline 
(vertical lines = SEM), 
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Figure 9. Mean bcx^ temperature as a function of morphine dose for 
chicks treated with the selective kappa antagonist nor-
binaltorphamine (10 pg/5 pi icv) or saline (vertical lines 
= SEM) 
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terms were not significant. Subsequent analysis of the bocfy 
tençerature data demonstrated that the mean bo^ temperatures of 
the icv/nor-BNI grotçs were significantly higher than the mean botty 
temperatures of the icv/saline groups at both the 0.0 [t(72) = 
2.19, p<.05] and 2.5 rag/kg [t(72) = 1.66, p<.05] morphine dose 
treatments. 
Discussion 
Experiment 3 was was designed to evaluate the contribution of 
kappa receptor activity in the expression of morphine-induced 
hyperalgesia. Morphine dose-response effects on thermal 
nociception were examined following icv administration of the 
selective kappa antagonist nor-BNI or saline in young domestic 
fowl. As in the previous two experiments, morphine produced a 
dose-dependent decrease in mean jump latency (i.e., hyperalgesia) 
in the icv saline groups. Selective kappa antagonism attenuated 
this hyperalgesia effect at the highest morphine dose. These 
results are consistent with the notion of kappa receptor 
involvement in nociception (Upton, Gonzalez, & Sewell, 1983; Wood, 
1984) and the observation that higher morphine doses are less 
selective at mu sites and, thereby, co-activate kappa sites 
(Martin, 1984). 
As in Experiments 1 and 2, morphine produced a dose-dependent 
decrease in mean respirations. Consistent with the notion that 
morphine-induced respiratory depression involves the activation of 
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mu receptors (Green, 1959; Ling et al., 1985; McGilliard & 
Takemori, 1978, McXSueen, 1983), selective kappa antagonism failed 
to attenuate this morphine effect. The present results suggest 
that morphine-induced respiratory depression involves systems not 
dependent upon kappa activation. 
In the present experiment, morphine-induced hypothermia was 
not observed in the icv/saline groups. These results are 
inconsistent with the results fron Experiments 1 and 2 and earlier 
research that demonstrated morphine-induced hypothermia in domestic 
fowl (Frohm & Wallnau, 1983). The failure to observe such a 
morphine effect may be related to the effects of social separation 
on core bo<ty temperatures as discussed in Experiment 1. That kappa 
agonists produced hyperthermia suggests thermoregulatory systems 
are dependent, in part, upon kappa activity. These hyperthermic 
effects, like those described in Experiment 2, suggest that 
kappa-mediated opioid systems may play an important role in stress 
effects on thermoregulation. 
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GENERAL DISCUSSION 
Current evidence supports the view that opioid receptors 
(i.e., itiu, kappa, & delta) exhibit differential involvement in the 
regulation of a variety of biological functions. Research with 
selective agonists has demonstrated 1) mu receptor involvement in 
nociception, respiration, food transit, thermoregulation, and the 
development of dependence, 2) kappa receptor involvement in 
nociception, sedation, feeding, and urination and, 3) delta 
receptor involvement in reward, seizures, and, to a lesser extent, 
nociception (for review see Tam, 1989). Opioid systems are clearly 
inportant in nociception. The significance of such systems in the 
modulation of other behaviors, however, is unknown. 
Opiate agonists typically produce analgesia in a variety of 
species (Martin, 1984). Previous research, however, demonstrated 
that morpAiine produced a strain-dependent hyperalgesic response to 
a noxious thermal stimulus in young domestic fcwl (Hughes, in 
press-b). This hyperalgesic effect was naloxone-reversible 
(Hughes, in press-a) and exhibited dose and tenparal 
characteristics typical of morphine analgesic effects (Sufka & 
Hughes, 1990b). These observations suggest opioid system(s) 
involvement in the expression of this paradoxical morphine effect. 
The recent development of relatively selective opiate agonists 
and antagonists has made it possible to examine opioid receptor 
involvement in the regulation of various behaviors. The present 
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research sought to examine the contribution of various opioid 
receptors in the expression of morphine-induced hyperalgesia. 
In a series of three experiments, morphine dose-response 
effects on thermal nociception were evaluated following selective 
antagonism of either mu, delta, or kappa opioid receptors. ïWo 
additional dependent measures, core bo<^ tenperature and 
respirations, were included in the present research. These 
measures aided in the interpretation of the data for the thermal 
nociceptive tests. For example, the lack of a delta antagonist 
effect on morphine-induced hyperalgesia was not due to biologically 
inactive compound since the delta antagonist did produce 
significant hyperthermic effects. This does not exclude the 
possibility that the three antagonists do not share similar dose 
response curves for bioavailability on nociceptive systems. 
In the present research, mu, but not kappa or delta, 
antagonism attenuated morjMne-induced respiratory depression. 
These results are consistent with earlier research that 
demonstrated mu-mediatâon of morphine-induced respiratory 
depression (Green, 1959; Ling et al., 1985; McGilliard & Takemori, 
1978; McQueen, 1983). For bo<fy temperature, morjMne-induced 
hypothermia was not attenuated by mu antagonism. These results are 
inconsistent witJi earlier research that demonstrated morphine 
effects on bo(ty temperature results through mu activation (Tam, 
1989). Kappa and delta antagonists, however, produced a 
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hyperthermic response that was independent of morphine effects. 
These results suggest that endogenous thermoregulatory systems are 
dependent, in part, upon functional kappa and delta sites and, that 
in domestic fowl, morphine-induced hypothermia is not entirely 
dependent upon mu ^sterns. The function of such opioid systems on 
stress-induced hypothermia remains to be determined. 
In the present research, as is cmmon in similar research with 
rats and mice, changes in nociception were inferred from changes in 
response latencies elicited by a noxious thermal stimulus. The 
assumption underlying this inference is that increases and 
decreases in some aspect of nociception are reflected in decreases 
and increases respectively, in response latency. Further support 
for this inference is provided fcy research that demonstrated 
thermal stimulus intensity is inversely related to response latency 
(Hughes & Sufka, in press). Animals typically did not perform the 
jump response on ambient temperature tests. This failure to 
respond on ambient temperature tests suggests that chicks were 
responding to the thermal stimulus of the test apparatus and not to 
its confinement characteristics. 
In each experiment, morphine produced a dose-dependent 
decrease in mean junp latencies. This hyperalgesia effect was 
attenuated by the mu antagonist at the two highest morphine doses 
(i.e., 2.5, & 5.0 mg/kg). The kappa antagonist attenuated 
this hyperalgesia response only at the highest morphine dose (i.e.. 
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5.0 mg/kg)y whereas the delta antagonist was ineffective in 
attenuating morphine-induced hyperalgesia. 
The pattern of opioid receptor involvement (primarily mu, 
partial kappa, & no delta) in hyperalgesia is strikingly similar to 
the pattern of opioid receptor involvement observed in 
morphine-induced analgesia. For example, the analgesic effects of 
opiates, like morphine, are primarily mediated through mu receptors 
located in the PAG (Yaksh & Ru(fy, 1978). Hi sites on the raphe 
magnus, locus ceruleus, and nucleus reticularis gigantocellularis 
have recently been iirplicated in contributing to morphine analgesia 
(Wood & Iyengar, 1988). Although kaH» agonists are potent 
analgesics (Giordano & Barr, 1987; Rraner & Hill, 1981; Upton et 
al., 1983), they are only analgesic in areas of primary afferent 
input (i.e., trigeminal nuclei & spinal cord dorsal horn; Skingle & 
Tyers, 1980; Wood, Rackham, & Richard, 1981). Delta agonists are 
relatively ineffective in eliciting analgesia (Ronai, Berzeti, 
Szekeley, Miglecz, Kurgyis, & Bajusz, 1981). Furthermore, current 
research suggests that delta ligands exert their antinociceptive 
effects through mu sites (Clark et al., 1986; Itzhak & Pasternak, 
1987). The results from the present research parallels the pattern 
of opioid receptor involvement in nociception observed in other 
species except that the nociceptive response (i.e, hyperalgesia) is 
in the opposite direction. 
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Converging evidence suggests that multiple opioid receptor 
types participate at several levels in the nociceptive neuraxis to 
modulate nociceptive stimuli. Autoradiographic studies have 
identified populations of mu, delta, and kappa receptors to various 
CNS loci (for review see Goodman, Adler, & Pasternak, 1988). Most 
notable loci are distinct populations of mu receptors located in 
the PAG and various raphe nuclei and mu, delta, and kappa receptors 
located in the substantia gelatinosa of the spinal cord. This 
regional distribution corresponds well with the observation that 
analgesia can be elicited by both mu receptor activation at PAG 
loci (Yaksh & Ru<^, 1978) and kappa receptor activation at spinal 
loci (Wood et al., 1981). The contribution of spinal and 
supraspinal opioid mechanisms in the paradoxical Inyperalgesic 
action of morphine in domestic fowl remains to be determined. 
The contribution of monoaminergic systems in the expression of 
morphine-induced analgesia is well documented. Both serotonin (5-
HT) and norepinephrine (NE) have been proposed as neurotransmitters 
of the descending neuraxis. For exairple, morphine-induced 
analgesia was attenuated by S-KT antagonists (Messing & Lytle, 
1977), lesions to the 5-HT-secreting nucleus raphe magnus (Proudfit 
& Anderson, 1975), and 5-HT spinal cord depletion with 5,6 
hydro:ytryptamine (Vogt, 1974). Additionally, the analgesic 
effects of morphine were altered by either NE-alpha antagonists 
(Proudfit & Hammond, 1981) or lesions to the pontine A-1 cell group 
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(Kuraishir Harada, Aratari, Satoh, & Tagakif 1983). The 
contribution of monoaminergic ^stens in the hyperalgesic action of 
morphine in dranestic fowl remains to be determined. 
The ability of narcotic analgesics to allevate pain varies 
across individuals. This variablity limits the use of many 
pharmacotherapeutics as analgesics. Rirther research into the 
neural mechanisms subserving the paradoxical effects of morjAiine in 
this animal model may define possible pharmacological variations 
relevant to the utility of opiate drugs as analgesics. 
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